首页> 外文期刊>Gynecologic Oncology: An International Journal >Intraoperative electron beam radiotherapy and extended surgical resection for gynecological pelvic recurrent malignancies with and without external beam radiation therapy: Long-term outcomes
【24h】

Intraoperative electron beam radiotherapy and extended surgical resection for gynecological pelvic recurrent malignancies with and without external beam radiation therapy: Long-term outcomes

机译:术中电子束放射疗法和扩大手术切除术在有无外来放射线治疗的妇科盆腔复发性恶性肿瘤中的长期疗效

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To analyze prognostic factors in patients treated with intraoperative electrons containing resective surgical rescue of locally recurrent gynecological cancer (LRGC). Methods From January 1995 to December 2012, 35 patients with LRGC [uterine cervix (57%), endometrial (20%), ovarian (17%), vagina (6%)] underwent extended [multiorgan (54%), bone (9%), soft tissue (54%), vascular (14%)] surgery and intraoperative electron-beam radiation therapy [IOERT (10-15 Gy)] to the pelvic recurrence tumor bed. Sixteen (46%) patients also received external beam radiation therapy [EBRT (30.6-50.4 Gy)]. Survival outcomes were estimated using the Kaplan-Meier method, and risk factors were identified by univariate and multivariate analyses. Results Median follow-up time for the entire cohort of patients was 46 months (range, 3-169). Ten-year rates for locoregional control (LRC) and overall survival (OS) were 58 and 16%, respectively. On multivariate analysis non-EBRT at the time of pelvic re-recurrence [HR 4.15; p = 0.02], no tumor fragmentation [HR 0.13; p = 0.05] and time interval from primary tumor to LRR < 24 months [HR 5.16; p = 0.01], retained significance with regard to LRR. Non-EBRT at the time of pelvic re-recurrence [HR 4.18; p = 0.02] and time interval from primary tumor to LRR < 24 months [HR 6.67; p = 0.02] showed a significant association with OS after adjustment for other covariates. Conclusions EBRT treatment integrated for rescue, time interval for relapse ≥ 24 months, and not multi-involved fragmented resection specimens are associated with improved LRC in patients with LRGC in the pelvis. Present results suggest that a significant group of patients may benefit from EBRT treatment integrated with extended surgery and IOERT.
机译:目的分析术中电子手术治疗局部复发性妇科癌(LRGC)的预后因素。方法1995年1月至2012年12月,对35例LRGC [子宫宫颈(57%),子宫内膜(20%),卵巢(17%),阴道(6%)]的患者进行了[多器官(54%),骨(9) %),软组织(54%),血管(14%)]和​​术中电子束放射治疗[IOERT(10-15 Gy)]到盆腔复发性肿瘤床。 16名(46%)患者也接受了外部束放射治疗[EBRT(30.6-50.4 Gy)]。使用Kaplan-Meier方法评估生存结果,并通过单因素和多因素分析确定危险因素。结果整个患者队列的中位随访时间为46个月(范围3-169)。局部区域控制(LRC)和总生存(OS)的十年率分别为58%和16%。在多因素分析中,骨盆复发时的非EBRT [HR 4.15; p = 0.02],无肿瘤碎片[HR 0.13; p = 0.05],从原发肿瘤到LRR的时间间隔<24个月[HR 5.16; p = 0.01],在LRR方面保持显着性。骨盆复发时的非EBRT [HR 4.18; p = 0.02],从原发肿瘤到LRR的时间间隔<24个月[HR 6.67; p = 0.02]在调整其他协变量后显示与OS显着相关。结论EBRT综合治疗可挽救,复发间隔时间≥24个月,且无多处碎裂切除标本与骨盆LRGC患者的LRC改善相关。目前的结果表明,很大一部分患者可能会受益于EBRT治疗以及延长手术和IOERT的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号